home / stock / snwv / snwv news


SNWV News and Press, Sanuwave Health Inc From 01/10/24

Stock Information

Company Name: Sanuwave Health Inc
Stock Symbol: SNWV
Market: OTC
Website: sanuwave.com

Menu

SNWV SNWV Quote SNWV Short SNWV News SNWV Articles SNWV Message Board
Get SNWV Alerts

News, Short Squeeze, Breakout and More Instantly...

SNWV - SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023

SANUWAVE is pleased to announce preliminary revenues of $6.6 million to $6.8 million for the fourth quarter ended December 31, 2023. This represents a new quarterly revenue record for the Company. Q4 2023 revenue increased 20% to 24% over Q4 2022 and in excess of 30% versus the third quart...

SNWV - SANUWAVE Health GAAP EPS of -$0.03, revenue of $5M; initiates Q4 outlook

2023-11-10 05:05:07 ET More on SANUWAVE Health Sanuwave Health eyes Nasdaq listing, announces merger with SEP Acquisition Financial information for SANUWAVE Health For further details see: SANUWAVE Health GAAP EPS of -$0.03, revenue of $5M; initiates Q4 outlook

SNWV - SANUWAVE Announces Q3 2023 Financial Results

EDEN PRAIRIE, MN,, Nov. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced its 3rd quarter 2023 results. ...

SNWV - SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results

EDEN PRAIRIE, MN  - ( NewMediaWire ) - November 08, 2023 -  SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation wound care products, will host a live conference call on Friday, November 10, 2023, at 8:00AM (ET) to present the Q3 2023 financial results.   ...

SNWV - SANUWAVE Health sees Q3 revenue of $4.7-$4.9M

2023-10-10 07:56:17 ET SANUWAVE Health ( OTCQB:SNWV ) expects Q3 revenue in the range of $4.7 to $4.9 million. “Overall revenues in the quarter were positively impacted by significant growth in the core UltraMIST product lines which constituted greater than 90% of SANUWAVE&...

SNWV - SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023

SANUWAVE is Pleased to Announce Preliminary Revenues of $4.7 Million to $4.9 Million for the Third Quarter Ended September 30, 2023 Results Indicate 13-18% Growth Rate Over Q3 2022 UltraMist Revenues (systems and consumables) Increased in Excess of 25% Year On Year and by Greater Th...

SNWV - Sanuwave Health eyes Nasdaq listing announces merger with SEP Acquisition

2023-08-23 17:06:42 ET More on SEP Acquisition Corp., SANUWAVE Health, etc. SANUWAVE to share monthly performance data SANUWAVE Health says shares will no longer be traded on OTC market SANUWAVE Health inks $3M private placement financing SANUWAVE Health inks...

SNWV - SANUWAVE Health, Inc., a Leading Provider of FDA Approved Next-Generation Wound Care Products, Enters into a Merger Agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp., a Nasdaq-Listed Company

·       SANUWAVE Health Inc. (OTCQB: SNWV) has entered into a definitive merger agreement with SEP Acquisition Corp. (Nasdaq: SEPA). Upon closing, the combined company is expected to trade on the Nasdaq Capital Market under the symbol “SNWV”. &...

SNWV - SANUWAVE Announces Q2 2023 Financial Results

EDEN PRAIRIE, MN, Aug. 11, 2023 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the “Company” or “SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced its 2nd quarter 2023 results. For the three months ended...

SNWV - SANUWAVE Will Host a Live Conference Call on August 11, 2023 at 8:30 AM (EDT) to Present Its Q2 2023 Financial Results

EDEN PRAIRIE, MN, Aug. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, August 11, 2023, at 8:30AM (EDT) to present its Q2 2023 financ...

Previous 10 Next 10